+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urticaria Drug"

From
From
From
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Urticaria Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of allergic reactions and other immune-related conditions. Urticaria, also known as hives, is a common skin condition characterized by itchy, raised welts on the skin. Urticaria drugs are used to reduce the symptoms of the condition, such as itching, swelling, and redness. These drugs can be administered orally, topically, or intravenously, depending on the severity of the condition. Commonly used urticaria drugs include antihistamines, corticosteroids, and leukotriene receptor antagonists. Some companies in the Urticaria Drug market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, and Merck. Show Less Read more